microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer

@inproceedings{Ueno2013microRNA183IA,
  title={microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer},
  author={Koji Ueno and Hiroshi Hirata and Varahram Shahryari and Guoren Deng and Yuichiro Tanaka and Z. Laura Tabatabai and Yuji Hinoda and Rajvir Dahiya},
  booktitle={British Journal of Cancer},
  year={2013}
}
Background:The purpose of this study was to identify prostate cancer (PC) oncogenic microRNAs (miRs) based on miR microarray and to investigate whether these oncogenic miRs may be useful as PC biomarkers.Methods:Initially, we carried out miR microarray and real-time PCR using RWPE-1, PC-3, DU-145 and LNCaP cells. To investigate the function of miR-183, we used a miR-183 knockdown inhibitor in cell growth and wound-healing assays. We used several algorithms and confirmed that they are directly… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

  • A Schaefer, M Jung, +7 authors K Jung
  • Int J Cancer
  • 2010
Highly Influential
4 Excerpts

Cancer statistics , 2010

  • Y Kawano, M Kitaoka, Y Hamada, MM Walker, J Waxman, RM Kypta
  • CA Cancer J Clin
  • 2006
Highly Influential
2 Excerpts

cancer progression

  • H Ijichi, M Otsuka, +9 authors M Omata
  • 2004
Highly Influential
2 Excerpts

Similar Papers

Loading similar papers…